Cardlytics (CDLX) Enterprise Value (2016 - 2026)

Cardlytics has reported Enterprise Value for 11 years, with the latest figure at -$59.8 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 14.9% year-over-year to -$59.8 million; the trailing twelve-month figure through Mar 2026 stood at -$59.8 million (down 14.9% YoY), and the FY2025 full-year result was -$48.7 million, up 25.73% from the prior year.
• Enterprise Value for Q1 2026 stood at -$59.8 million, down from -$48.7 million in the prior quarter.
• The five-year high for Enterprise Value was -$44.0 million in Q3 2025, with the low at -$208.3 million in Q1 2022.
• Historically, Enterprise Value has averaged -$93.6 million across 5 years, with a median of -$90.1 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 66.05% — and 2026, when it decreased 14.9%.
• Cardlytics' Enterprise Value stood at -$121.9 million in 2022, then advanced by 24.67% to -$91.8 million in 2023, then increased by 28.57% to -$65.6 million in 2024, then advanced by 25.73% to -$48.7 million in 2025, then dropped by 22.75% to -$59.8 million in 2026.
• The last three Enterprise Value figures came in at -$59.8 million (Q1 2026), -$48.7 million (Q4 2025), and -$44.0 million (Q3 2025), per Business Quant data.